Lesinurad and Allopurinol Combination Extension Study in Gout

Registry ID

EUCTR2012-004389-16

Source registry

EUCTR

Status

Completed

Phase

PHASE3

Sponsor

Ardea Biosciences, Inc.

Start date

2013-05-27

Last update

2026-08-16

Conditions

• Gout

Summary

To assess the long-term efficacy and safety of lesinurad in combination with allopurinol

Locations

• , , Belgium
• , , Spain
• , , Germany

Related clinical trials

• A Study of Dotinurad Versus Allopurinol in Participants With Gout
• A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants
• A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)
• Immediate Prescription of a Hypouricemic Treatment, Febuxostat, Compared to Its Delayed Administration
• The Remote Monitoring of Gout Feasibility Study in Primary Care
• the Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or More

View on source registry